Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine augmentation in SRI-refractory obsessive-compulsive disorder
IRCT2014031717045N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in obsessive compulsive disorder (OCD) comparing Lamotrigine augmentation with Placebo augmentation (2 arms). Started Apr 2014; status: completed.
02
Drugs
lamotrigine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT2014031717045N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014031717045N1.